Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten de Wit

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
Rheumatology (Oxford, England)|May 7, 2020
The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission statusCátia Duarte, Eduardo Santos, José A P da Silva, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
The Journal of Rheumatology|April 17, 2015
Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRPPeter P Cheung, Maarten de Wit, Clifton O Bingham, et al.
Rheumatology (Oxford, England)|May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studiesLaure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
BMC Rheumatology|July 8, 2021
Researchers' perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence studyShahrzad Salmasi, Ayano Kelly, Susan J Bartlett, et al.
The Journal of Rheumatology|November 3, 2005
Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessmentJohn R Kirwan, Monica Ahlmén, Maarten de Wit, et al.
Annals of the Rheumatic Diseases|December 15, 2015
Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritisSofia Ramiro, Josef S Smolen, Robert Landewé, et al.
The Journal of Rheumatology|February 17, 2019
Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set DevelopmentSusan Humphrey-Murto, Richard Crew, Beverley Shea, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual MeetingNiti Goel, Denis O'Sullivan, Maarten de Wit, et al.
RMD Open|February 6, 2021
Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patientsCatia Duarte, Eduardo José Ferreira Santos, Ricardo J O Ferreira, et al.
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
Rheumatology (Oxford, England)|May 7, 2020
The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission statusCátia Duarte, Eduardo Santos, José A P da Silva, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
The Journal of Rheumatology|April 17, 2015
Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRPPeter P Cheung, Maarten de Wit, Clifton O Bingham, et al.
Rheumatology (Oxford, England)|May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studiesLaure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
BMC Rheumatology|July 8, 2021
Researchers' perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence studyShahrzad Salmasi, Ayano Kelly, Susan J Bartlett, et al.
The Journal of Rheumatology|November 3, 2005
Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessmentJohn R Kirwan, Monica Ahlmén, Maarten de Wit, et al.
Annals of the Rheumatic Diseases|December 15, 2015
Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritisSofia Ramiro, Josef S Smolen, Robert Landewé, et al.
The Journal of Rheumatology|February 17, 2019
Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set DevelopmentSusan Humphrey-Murto, Richard Crew, Beverley Shea, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual MeetingNiti Goel, Denis O'Sullivan, Maarten de Wit, et al.
RMD Open|February 6, 2021
Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patientsCatia Duarte, Eduardo José Ferreira Santos, Ricardo J O Ferreira, et al.
Pageof 21